Related Experiment Video

Updated: Apr 29, 2026

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

28.8K

[Pathogenesis of human metapneumovirus infection and research on attenuated live vaccine]

Mao-Zhi Tang1, Ying Dou, Xiao-Dong Zhao

  • 1Department of Nephritic Immunology, Children's Hospital of Chongqing Medical University, Chongqing 400014, China. tmzm0130@163.com.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|May 27, 2014
PubMed

Insights

Human metapneumovirus (hMPV) causes severe respiratory infections in young children, similar to RSV. Targeting viral glycosylation sites on the F protein may lead to new live attenuated vaccines.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Context:

  • Human metapneumovirus (hMPV) is a significant cause of pediatric acute respiratory infections.
  • hMPV shares clinical similarities with respiratory syncytial virus (RSV).
  • Infection prevalence is highest in winter-spring and affects infants under one year old.

Purpose:

  • To explore the role of host pattern recognition receptors (PRRs), specifically Toll-like receptors (TLRs) 3 and 4, in hMPV infection.
  • To investigate the potential of modifying the hMPV F protein for vaccine development.

Summary:

  • hMPV infection involves host innate immune responses recognizing viral pathogen-associated molecular patterns (PAMPs) via PRRs.
  • TLR3 and TLR4 are suggested to play crucial roles in the immune response to hMPV.
  • Site-directed mutagenesis and reverse genetics were used to create hMPV mutants lacking N-linked glycosylation sites on the F protein.

Impact:

  • Findings may elucidate the mechanisms of hMPV pathogenesis and immune evasion.
  • The development of recombinant mutant viruses could pave the way for novel attenuated live vaccines against hMPV.
  • Understanding TLR involvement could inform therapeutic strategies for hMPV infections.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

9.8K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

Related Concept Videos

Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
87
Vaccinations01:51

Vaccinations

Overview
44.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
82
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
23
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K